Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors
Open Access
- 1 August 2000
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (8) , 1057-1060
- https://doi.org/10.1023/a:1008334404825
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen ReceptorsJournal of Clinical Oncology, 2000
- Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast CancerJournal of Clinical Oncology, 1999
- Prediction of response to primary chemotherapy for operable breast cancerEuropean Journal Of Cancer, 1999
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.Journal of Clinical Oncology, 1998
- Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST piBritish Journal of Cancer, 1996
- Primary chemotherapy in surgically resectable breast cancerCA: A Cancer Journal for Clinicians, 1995
- Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.Journal of Clinical Oncology, 1995
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cmAnnals of Oncology, 1991